Harvard Medical School Diabetes Update 2023

Overview

Harvard Medical School Diabetes Update 2023 is a comprehensive on-demand education program designed to provide clinicians with practical, evidence-based updates and strategies for state-of-the-art diabetes care. Originally delivered via live streaming from May 3 to 6, 2023, this program covers the latest advances in diabetes therapies, technologies, and management practices, with a focus on optimizing treatment plans and addressing associated complications.

On-demand endocrinology & metabolism education — accessible anytime, anywhere.

Agenda

This program offers a detailed and practical agenda focusing on key aspects of diabetes care, from diagnosis to management and treatment of complications. Sessions include lectures, clinical case discussions, and interactive breakout sessions led by experts in the field.

• Welcome and Introduction — A. Enrique Caballero, MD
• Diabetes Report Card: How Are We Doing in Diabetes Care? — A. Enrique Caballero, MD
• Practical Approach to Identifying Different Types of Diabetes in Clinical Practice — Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC
• Current Understanding of Diabetes Phenotypes — Miriam Udler, MD, PhD
• Q & A and Clinical Cases Discussion — Lucia Novak, MSN, ANP-BC, BC-ADM, CDTC and Miriam Udler, MD, PhD
• Type 2 Diabetes in the Elderly: What You Need to Know — Medha Munshi, MD
• A Practical Approach to Anti-Diabetes Medication Selection — Marie McDonnell, MD
• Q & A and Clinical Cases Discussion — Medha Munshi, MD and Marie McDonnell, MD
• Current Nutrition Recommendations and Guidelines — Laura Andromalos, MS, RD, RN, CSOWM, CDCES
• The Carbohydrate-Insulin Model: A Novel Approach to Diabesity — David Ludwig, MD, PhD
• Q & A and Clinical Case Discussion — Laura Andromalos, MS, RD, CSOWM, CDCES and David Ludwig, MD, PhD
• Welcome, Recap of Day 1, and Description of Day 2 Activities — A. Enrique Caballero, MD
• Non-Alcoholic Fatty Liver Disease — Scott Isaacs, MD, FACP, FACE
• Exercise in Diabetes Care: The Basics on What Works and Why — Jane Reusch, MD
• Exercise Recommendations: Building a Tailored Program considering Diabetes Status and Complications — Jacqueline Shahar, MEd, RCEP, CDCES
• Q & A and Clinical Case Discussion — Jane Reusch, MD and Jacqueline Shahar, MEd, RCEP, CDCES
• Pharmacological Management: Individualizing Therapy — W. Scott Butsch, MD, MSc
• Surgical Management: Why and When? — Philip R. Schauer, MD
• Q & A and Clinical Cases Discussion — W. Scott Butsch, MD, MSc and Philip R. Schauer, MD
• Addressing LDL: Cholesterol as Primary Target — Om Ganda, MD
• Triglycerides and HDL: Cholesterol Management—When and How? — Aruna Pradhan, MD, MPH
• Q & A and Clinical Case Discussion — Om Ganda, MD and Aruna Pradhan, MD, MPH
• Welcome, Recap of Day 2 and Description of Day 3 Activities — A. Enrique Caballero, MD
• The Microbiome in Obesity, Diabetes, and Related Disorders — Patricia Davidson, DCN, RDN, LDN, CDCES, FAND, CHSE, FADCES
• Clinical Evaluation of the Patient with Hypertension — Naomi Fisher, MD
• Current Recommendations for the Treatment of Hypertension — John Forman, MD
• Q & A and Clinical Case Discussion — Naomi Fisher, MD and John Forman, MD
• Evaluation of CV Risk: Practical Recommendations — Jorge Plutzky, MD
• Reducing CV Risk in the Patient with Diabetes: A Comprehensive Approach — Christopher Cannon, MD
• Q & A and Clinical Case Discussion — Jorge Plutzky, MD and Christopher Cannon, MD
• Continuous Glucose Monitoring: A 2023 Vision — Devin Steenkamp, MD
• Insulin Pumps, Closing the Loop: Where Do We Stand? — Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP
• Q & A and Clinical Cases Discussion — Devin Steenkamp, MD and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP
• Welcome, Recap of Day 3 and Description of Day 4 Activities — A. Enrique Caballero, MD
• Traditional Medications (Biguanides, SUs, TZDs, Alpha-Glucosidase Inhibitors) — A. Enrique Caballero, MD
• Incretin-Based Therapies (DPP-IV Inhibitors and GLP-1 RA) — Juan P. Frias, MD
• SGLT-2 Inhibitors — Silvio Inzucchi, MD
• Insulin Therapy — Anne L. Peters, MD
• Q & A and Clinical Cases Discussion — A. Enrique Caballero, MD, Juan P. Frias, MD, Silvio Inzucchi, MD, and Anne L. Peters, MD
• How Do Race and Ethnicity Influence Diabetes Management Decisions? — A. Enrique Caballero, MD
• Identifying Community-Based Resources to Help Patients with Diabetes — Josh Trautwein
• Q & A Clinical Cases Discussion — A. Enrique Caballero, MD
• The Road towards Equity in Diabetes Care — Janet Brown-Friday, RN, MSN, MPH
• Closing Remarks — A. Enrique Caballero, MD

Speakers

• A. Enrique Caballero, MD
• Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC
• Miriam Udler, MD, PhD
• Medha Munshi, MD
• Marie McDonnell, MD
• Laura Andromalos, MS, RD, RN, CSOWM, CDCES
• David Ludwig, MD, PhD
• Scott Isaacs, MD, FACP, FACE
• Jane Reusch, MD
• Jacqueline Shahar, MEd, RCEP, CDCES
• W. Scott Butsch, MD, MSc
• Philip R. Schauer, MD
• Om Ganda, MD
• Aruna Pradhan, MD, MPH
• Patricia Davidson, DCN, RDN, LDN, CDCES, FAND, CHSE, FADCES
• Naomi Fisher, MD
• John Forman, MD
• Jorge Plutzky, MD
• Christopher Cannon, MD
• Devin Steenkamp, MD
• Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP
• Juan P. Frias, MD
• Silvio Inzucchi, MD
• Anne L. Peters, MD
• Josh Trautwein
• Janet Brown-Friday, RN, MSN, MPH

Target Audience

This program is intended for clinicians involved in the care of patients with diabetes, including endocrinologists, primary care physicians, nurse practitioners, physician assistants, diabetes educators, dietitians, and other healthcare professionals seeking to update their knowledge on current diabetes management approaches and emerging therapies.

Why This Topic Matters

Harvard Medical School Diabetes Update 2023 addresses critical challenges in diabetes care that persist despite advances in treatment and technology. This comprehensive endocrinology education provides clinicians with current, evidence-based information to support optimized patient management, including complex cases and comorbidities.

Available through MedHub Central as on-demand education, this program supports healthcare professionals in strengthening their expertise and confidence in providing individualized, up-to-date diabetes care aligned with the latest scientific guidelines and clinical innovations.